The treatment landscape in thyroid cancer: a focus on cabozantinib
SP Weitzman, ME Cabanillas - Cancer management and research, 2015 - Taylor & Francis
Although patients with thyroid cancer generally fare well, there is a subset for which this is
not necessarily true. Progress in understanding the molecular aberrations in thyroid cancer …
not necessarily true. Progress in understanding the molecular aberrations in thyroid cancer …
The treatment landscape in thyroid cancer: a focus on cabozantinib
SP Weitzman, ME Cabanillas - Cancer Management and …, 2015 - search.proquest.com
Although patients with thyroid cancer generally fare well, there is a subset for which this is
not necessarily true. Progress in understanding the molecular aberrations in thyroid cancer …
not necessarily true. Progress in understanding the molecular aberrations in thyroid cancer …
The treatment landscape in thyroid cancer: A focus on cabozantinib
SP Weitzman, ME Cabanillas - Cancer …, 2015 - mdanderson.elsevierpure.com
Although patients with thyroid cancer generally fare well, there is a subset for which this is
not necessarily true. Progress in understanding the molecular aberrations in thyroid cancer …
not necessarily true. Progress in understanding the molecular aberrations in thyroid cancer …
The treatment landscape in thyroid cancer: a focus on cabozantinib.
SP Weitzman, ME Cabanillas - Cancer Management and Research, 2015 - europepmc.org
Although patients with thyroid cancer generally fare well, there is a subset for which this is
not necessarily true. Progress in understanding the molecular aberrations in thyroid cancer …
not necessarily true. Progress in understanding the molecular aberrations in thyroid cancer …
The treatment landscape in thyroid cancer: a focus on cabozantinib
SP Weitzman, ME Cabanillas - Cancer management …, 2015 - pubmed.ncbi.nlm.nih.gov
Although patients with thyroid cancer generally fare well, there is a subset for which this is
not necessarily true. Progress in understanding the molecular aberrations in thyroid cancer …
not necessarily true. Progress in understanding the molecular aberrations in thyroid cancer …
The treatment landscape in thyroid cancer: a focus on cabozantinib
SP Weitzman, ME Cabanillas - Cancer Management and Research, 2015 - go.gale.com
Although patients with thyroid cancer generally fare well, there is a subset for which this is
not necessarily true. Progress in understanding the molecular aberrations in thyroid cancer …
not necessarily true. Progress in understanding the molecular aberrations in thyroid cancer …
[HTML][HTML] The treatment landscape in thyroid cancer: a focus on cabozantinib
SP Weitzman, ME Cabanillas - Cancer Management and Research, 2015 - ncbi.nlm.nih.gov
Although patients with thyroid cancer generally fare well, there is a subset for which this is
not necessarily true. Progress in understanding the molecular aberrations in thyroid cancer …
not necessarily true. Progress in understanding the molecular aberrations in thyroid cancer …
The treatment landscape in thyroid cancer: a focus on cabozantinib
SP Weitzman, ME Cabanillas - Cancer Management and Research, 2015 - dovepress.com
Although patients with thyroid cancer generally fare well, there is a subset for which this is
not necessarily true. Progress in understanding the molecular aberrations in thyroid cancer …
not necessarily true. Progress in understanding the molecular aberrations in thyroid cancer …
[引用][C] The treatment landscape in thyroid cancer: a focus on cabozantinib
M Cabanillas, S Weitzman - Cancer Management and Research, 2015 - cir.nii.ac.jp